Home / Resource Library / Consolidative HDC-ASCT versus non-myeloablative immunochemotherapy for patients with primary CNS lymphomaConsolidative HDC-ASCT versus non-myeloablative immunochemotherapy for patients with primary CNS lymphoma ASH 2022